Compare RGEN & SSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | SSL |
|---|---|---|
| Founded | 1981 | 1950 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.4B |
| IPO Year | 1995 | 2002 |
| Metric | RGEN | SSL |
|---|---|---|
| Price | $181.13 | $12.49 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 12 | 1 |
| Target Price | ★ $167.67 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 05-05-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.30 | $3.79 |
| Revenue Next Year | $14.52 | $4.39 |
| P/E Ratio | $751.21 | ★ $13.51 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $5.24 |
| 52 Week High | $188.73 | $14.37 |
| Indicator | RGEN | SSL |
|---|---|---|
| Relative Strength Index (RSI) | 76.48 | 65.29 |
| Support Level | $156.65 | $12.26 |
| Resistance Level | N/A | $13.69 |
| Average True Range (ATR) | 6.79 | 0.26 |
| MACD | 1.81 | 0.11 |
| Stochastic Oscillator | 84.69 | 96.34 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.